B. Braun Renal Therapies Division Announces Enhanced Offerings for Hemodialysis System

BETHLEHEM, Pa., Nov. 15, 2011 /PRNewswire/ -- Improving staff efficiency and providing greater safety for renal therapy patients, B. Braun Medical Inc. (B. Braun) announced today the availability of an 1100g Solcart B Cartridge for use with the Dialog⁺ Hemodialysis System, the leading method used in the treatment of patients with kidney failure.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO )

The 1100g Solcart B cartridge touts the highest volume capacity of any B. Braun Solcart B bicarbonate cartridge, which until now had a maximum volume of 760 grams. In addition to being more economical and producing less waste, the larger size cartridge will allow Solcart B to be used for patients requiring customized therapies.

"B. Braun is adding the 1100g Solcart B cartridge for Dialog⁺ Hemodialysis Systems to provide customers with a cartridge ideal for customized therapies," said Samuel Amory, Vice President, Medical Technology Division for B. Braun Medical Inc. "The Dialog⁺ Hemodialysis System continues to incorporate greater convenience for both clinicians and renal therapy patients through advanced products like the 1100g Solcart B cartridge."

The Solcart B cartridge with sodium hydrogen carbonate powder for hemodialysis is a practical alternative to liquid alkaline bicarbonate hemodialysis concentrate and central mixing systems. Benefits include easy piercing, a design for convenient storage prior to use and a user friendly design.

For more information on the Solcart B cartridge for the Dialog⁺ Hemodialysis System or to request a demonstration please visit www.bbraunusa.com or call 800.848.2066.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise^®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at [email protected] or visit B. Braun at http://bbraunusa.com/.

SOURCE B. Braun